The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
Abstract Glutamatergic excitotoxicity is hypothesised to underlie synaptic loss in schizophrenia pathogenesis, but it is unknown whether synaptic markers are related to glutamatergic function in vivo. Additionally, it has been proposed that N-acetyl aspartate (NAA) levels reflect neuronal integrity....
Main Authors: | Ellis Chika Onwordi, Thomas Whitehurst, Ayla Mansur, Ben Statton, Alaine Berry, Marina Quinlan, Declan P. O’Regan, Maria Rogdaki, Tiago Reis Marques, Eugenii A. Rabiner, Roger N. Gunn, Anthony C. Vernon, Sridhar Natesan, Oliver D. Howes |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-021-01515-3 |
Similar Items
-
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
by: Ellis Chika Onwordi, et al.
Published: (2020-01-01) -
Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweight
by: Jeremy D. Coplan, et al.
Published: (2014-01-01) -
Phase interference multiecho MRI to determine hepatic and cardiac fat content
by: O'Regan, Declan
Published: (2008) -
Translational PET imaging research
by: Richard J. Hargreaves, et al.
Published: (2014-01-01) -
N-acetyl-aspartate level is decreased in the prefrontal cortex in subjects at-risk for schizophrenia.
by: Marine eMondino, et al.
Published: (2013-09-01)